Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study

Abstract Background To provide basic demographic information and clinicopathologic features of ophthalmic Rosai–Dorfman disease (RDD) with a literature review. Methods A multi-centre retrospective case series reviewing all patients with histopathologically confirmed ophthalmic RDD at three tertiary...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tariq A. Alzahem, Antonio Augusto Cruz, Azza M. Y. Maktabi, Fernando Chahud, Hind Alkatan
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/b68b8218af734c1f8f9d60defe58acfd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b68b8218af734c1f8f9d60defe58acfd
record_format dspace
spelling oai:doaj.org-article:b68b8218af734c1f8f9d60defe58acfd2021-11-28T12:42:18ZOphthalmic Rosai–Dorfman disease: a multi-centre comprehensive study10.1186/s12886-021-02173-11471-2415https://doaj.org/article/b68b8218af734c1f8f9d60defe58acfd2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12886-021-02173-1https://doaj.org/toc/1471-2415Abstract Background To provide basic demographic information and clinicopathologic features of ophthalmic Rosai–Dorfman disease (RDD) with a literature review. Methods A multi-centre retrospective case series reviewing all patients with histopathologically confirmed ophthalmic RDD at three tertiary eye care centres between January 1993 and December 2018. Results Eleven eyes of eight patients with histopathologically confirmed ophthalmic RDD were included, with equal numbers of males and females. The median age was 40.25 years (range: 26.6–72.4). Two patients had familial RDD. The orbit was the most commonly involved site (90.9% eyes). One patient (one eye) presented with a scleral nodule, anterior uveitis and cystoid macular oedema. Visual acuity ranged from 20/25 to light perception. Six patients had an extra-nodal ophthalmic disease, and the remaining two had an associated submandibular lymphadenopathy (nodal RDD). Conclusions Ophthalmic RDD can be the only manifestation of this systemic disease, with the orbit being the most commonly involved site, exhibiting bone destruction, intracranial and/or sinus involvement and variable degree of visual loss. Ophthalmic familial RDD represent a severe form with a malignant course. Steroid monotherapy may be inadequate to control orbital RDD; thus, combined treatment is usually necessary. A comprehensive approach to assessment and management is recommended.Tariq A. AlzahemAntonio Augusto CruzAzza M. Y. MaktabiFernando ChahudHind AlkatanBMCarticleRosai–Dorfman diseaseOrbitFamilialHistopathologyLymphadenopathyOphthalmologyRE1-994ENBMC Ophthalmology, Vol 21, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Rosai–Dorfman disease
Orbit
Familial
Histopathology
Lymphadenopathy
Ophthalmology
RE1-994
spellingShingle Rosai–Dorfman disease
Orbit
Familial
Histopathology
Lymphadenopathy
Ophthalmology
RE1-994
Tariq A. Alzahem
Antonio Augusto Cruz
Azza M. Y. Maktabi
Fernando Chahud
Hind Alkatan
Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study
description Abstract Background To provide basic demographic information and clinicopathologic features of ophthalmic Rosai–Dorfman disease (RDD) with a literature review. Methods A multi-centre retrospective case series reviewing all patients with histopathologically confirmed ophthalmic RDD at three tertiary eye care centres between January 1993 and December 2018. Results Eleven eyes of eight patients with histopathologically confirmed ophthalmic RDD were included, with equal numbers of males and females. The median age was 40.25 years (range: 26.6–72.4). Two patients had familial RDD. The orbit was the most commonly involved site (90.9% eyes). One patient (one eye) presented with a scleral nodule, anterior uveitis and cystoid macular oedema. Visual acuity ranged from 20/25 to light perception. Six patients had an extra-nodal ophthalmic disease, and the remaining two had an associated submandibular lymphadenopathy (nodal RDD). Conclusions Ophthalmic RDD can be the only manifestation of this systemic disease, with the orbit being the most commonly involved site, exhibiting bone destruction, intracranial and/or sinus involvement and variable degree of visual loss. Ophthalmic familial RDD represent a severe form with a malignant course. Steroid monotherapy may be inadequate to control orbital RDD; thus, combined treatment is usually necessary. A comprehensive approach to assessment and management is recommended.
format article
author Tariq A. Alzahem
Antonio Augusto Cruz
Azza M. Y. Maktabi
Fernando Chahud
Hind Alkatan
author_facet Tariq A. Alzahem
Antonio Augusto Cruz
Azza M. Y. Maktabi
Fernando Chahud
Hind Alkatan
author_sort Tariq A. Alzahem
title Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study
title_short Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study
title_full Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study
title_fullStr Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study
title_full_unstemmed Ophthalmic Rosai–Dorfman disease: a multi-centre comprehensive study
title_sort ophthalmic rosai–dorfman disease: a multi-centre comprehensive study
publisher BMC
publishDate 2021
url https://doaj.org/article/b68b8218af734c1f8f9d60defe58acfd
work_keys_str_mv AT tariqaalzahem ophthalmicrosaidorfmandiseaseamulticentrecomprehensivestudy
AT antonioaugustocruz ophthalmicrosaidorfmandiseaseamulticentrecomprehensivestudy
AT azzamymaktabi ophthalmicrosaidorfmandiseaseamulticentrecomprehensivestudy
AT fernandochahud ophthalmicrosaidorfmandiseaseamulticentrecomprehensivestudy
AT hindalkatan ophthalmicrosaidorfmandiseaseamulticentrecomprehensivestudy
_version_ 1718407853668040704